Flavonoids Market Size
Global Flavonoids Market size was USD 953.17 Million in 2025 and is projected to touch USD 1.05 Billion in 2026 and USD 1.15 Billion in 2027 to USD 2.49 Billion by 2035, exhibiting a CAGR of 10.06% during the forecast period (2026-2035). The Global Flavonoids Market is increasingly shaped by ingredient-driven product launches where roughly 36% of new nutraceutical formulations include a flavonoid ingredient for antioxidant claims, about 29% of cosmetic launches reference flavonoid extracts for anti-inflammatory positioning, and nearly 21% of dietary supplement buyers prioritize standardized flavonoid concentrations for label claim consistency.
![]()
The US Flavonoids Market is seeing elevated adoption in dietary supplements and functional beverages. Approximately 38% of US supplement product developers now include flavonoid-rich extracts for cardiovascular and cognitive support positioning, about 27% of beverage formulators add flavonoids for antioxidant labeling, and close to 18% of ingredient purchasing teams specify standardized assay guarantees to satisfy institutional procurement requirements.
Key Findings
- Market Size: $0.95317 billion (2025) $1.05 billion (2026) $2.49 billion (2035) 10.06%.
- Growth Drivers: 35% consumer demand for natural antioxidants, 33% supplement inclusion rate, 29% beverage reformulation preference.
- Trends: 34% move to standardized extracts, 31% clean-label formulations, 23% cosmetics replacing synthetics.
- Key Players: BORDAS S.A., Biosynth Carbosynth, Merck KGaA, Ingredients by Nature LLC, Cayman Chemical Company & more.
- Regional Insights: North America 35%, Asia-Pacific 30%, Europe 25%, Middle East & Africa 10% (total 100%).
- Challenges: 31% lot variability concerns, 27% regulatory complexity, 25% extraction-scale hurdles.
- Industry Impact: 33% of reformulations include flavonoids for antioxidant claims, 22% reduced reliance on synthetic actives.
- Recent Developments: 32% of suppliers now offer microencapsulated formats and 28% provide certified assay documentation.
Unique market note: Flavonoid extracts are increasingly packaged as multi-application, standardized ingredients that serve food, supplement, cosmetic, and feed segments, with about one-third of development pipelines focused on stability and certification to accelerate cross-category adoption.
![]()
Flavonoids Market Trends
The Flavonoids Market is witnessing strong movement toward standardized extracts, label-friendly claims, and multifunctional use across nutrition and personal care. About 34% of manufacturers now supply standardized flavonoid extracts with guaranteed percent-active content to reduce formulation variability. Nearly 31% of product launches in the supplement and beverage spaces emphasize antioxidant or anti-inflammatory claims linked to flavonoid content. Retail and e-commerce channels are shifting product discovery: roughly 29% of consumers search specifically for flavonoid-containing products when buying antioxidant supplements. Clean-label and natural-positioning demands drive roughly 23% of cosmetic formulators to replace synthetic actives with plant-derived flavonoids. In animal nutrition, approximately 12% of formulators evaluate flavonoids to support gut health and oxidative resilience in feed trials. Regional sourcing and traceability now influence procurement: about 18% of buyers request certificate-backed origin and extraction-method disclosure for flavonoid raw materials. These dynamics encourage suppliers to focus on assay reproducibility, scalable extraction methods, and multi-use ingredient formats suitable for beverages, capsules, topical care, and feed premixes.
Flavonoids Market Dynamics
Rising interest in standardized extracts and multifunctional formulations
Commercial opportunity exists where suppliers can offer validated, multi-application flavonoid extracts. Approximately 32% of formulators prefer multi-use powders that work across beverages, capsules and topical systems, reducing SKU complexity. About 28% of large CPG and contract-manufacturing customers actively source standardized flavonoid concentrates to speed regulatory filing and label claims. Subscription and institutional channels are opening recurring-purchase corridors—roughly 20% of distributors now include ingredient re-order programs for high-use buyers. Value-add services such as assay certificates, microencapsulation for heat stability, and pre-blended systems are requested by nearly 24% of procurement teams as they seek turnkey ingredient solutions that shorten time-to-market.
Consumer demand for natural antioxidants and anti-inflammatory ingredients
Rising consumer interest in natural health solutions drives flavonoid uptake. Around 35% of consumers prefer natural antioxidants over synthetic alternatives, prompting formulators to include flavonoid extracts in 33% of new supplement launches. Functional-beverage developers indicate that nearly 30% of reformulations aimed at "clean label" formulation now substitute synthetic antioxidants with plant-derived flavonoids. This consumer-led driver propels vendor investment in scalable extraction and standardization processes to meet growing multi-channel demand.
Market Restraints
"Variability in raw-material composition and regulatory complexity"
Raw-material variability and complex regulatory frameworks restrain consistent market expansion. Approximately 31% of buyers cite lot-to-lot variation in flavonoid concentration as a procurement concern, which leads about 27% of formulators to require additional in-house standardization. Differing regional regulations for health and nutrition claims cause roughly 22% of manufacturers to delay product rollouts to ensure compliance across markets. Sourcing sustainable and traceable botanical feedstock adds cost pressure—about 18% of suppliers report higher input costs when origin-certification is requested—impacting margins and slowing rapid scaling in price-sensitive segments.
Market Challenges
"Extraction scalability and stability in finished formulations"
Scaling extraction while preserving bioactivity presents technical challenges for producers and formulators. Around 29% of smaller extractors experience yield variability when shifting from lab to pilot scale, and roughly 25% of formulators report reduced flavonoid stability in high-heat or low-pH matrices. Encapsulation and stabilization technologies are being adopted—about 21% of new ingredient launches include microencapsulation—to mitigate these issues, but such technologies add complexity and cost, creating a barrier for commodity-priced applications like animal feed and low-margin food products.
Segmentation Analysis
Segmentation spans both application and molecular type: application choices—Food & Beverage, Dietary Supplements, Healthcare, Cosmetics and Personal Care, Animal Feed—drive format, dosing and certification needs; type choices—Flavones, Anthocyanin, Flavanols, Anthoxanthin, Flavan-3-ols, Isoflavones—determine extract methods and analytical assays. The Global Flavonoids Market size was USD 953.17 Million in 2025 and is projected to touch USD 1.05 Billion in 2026 to USD 2.49 Billion by 2035, exhibiting a CAGR of 10.06% during the forecast period (2026-2035). Type- and application-level allocation affects supply-chain planning and R&D prioritization for stability and standardization efforts.
By Type
Flavones
Flavones are employed for anti-inflammatory and antioxidant positioning in supplements and cosmetics; roughly 20% of ingredient spec sheets request flavone-rich extracts for specific bioactivity claims. Industrial extractors focus on standardized apigenin and luteolin fractions to meet label expectations.
Flavones Market Size in 2026 accounted for approximately USD 0.210 Billion, representing about 20% share of the 2026 market; CAGR 10.06%.
Anthocyanin
Anthocyanin extracts are prized for color and antioxidant claims in beverages and functional foods; about 18% of formulators use anthocyanins to deliver both natural coloring and health positioning, particularly in beverage and confectionery applications.
Anthocyanin Market Size in 2026 accounted for approximately USD 0.189 Billion, representing about 18% share of the 2026 market; CAGR 10.06%.
Flavanols
Flavanols, known for vascular and cognitive support claims, appear in roughly 15% of supplement formulations targeted at heart and brain health; cocoa and tea-derived flavanols remain important commodity sources for these applications.
Flavanols Market Size in 2026 accounted for approximately USD 0.158 Billion, representing about 15% share of the 2026 market; CAGR 10.06%.
Anthoxanthin
Anthoxanthins are used for mild antioxidant efficacy and sensory neutrality in formulations where color impact must be minimized; about 12% of formulators select anthoxanthin-rich fractions for such applications.
Anthoxanthin Market Size in 2026 accounted for approximately USD 0.126 Billion, representing about 12% share of the 2026 market; CAGR 10.06%.
Flavan-3-ols
Flavan-3-ols are incorporated for strong antioxidant potency and are frequent in functional beverages and supplements; approximately 20% of application briefs specify flavan-3-ols for potency and sensory balance.
Flavan-3-ols Market Size in 2026 accounted for approximately USD 0.210 Billion, representing about 20% share of the 2026 market; CAGR 10.06%.
Isoflavones
Isoflavones are targeted in hormonal-support and bone-health supplements; about 15% of relevant formulations prefer soy- or red-clover-derived isoflavone concentrates that meet standardized assay requirements.
Isoflavones Market Size in 2026 accounted for approximately USD 0.158 Billion, representing about 15% share of the 2026 market; CAGR 10.06%.
![]()
By Application
Food and Beverage
Food and Beverage applications use flavonoids for antioxidant claims, natural coloring, and functional positioning; about 35% of total application demand comes from beverages and fortified foods due to ease of dose delivery and consumer acceptance.
Food and Beverage Market Size in 2026 accounted for approximately USD 0.368 Billion, representing about 35% share of the 2026 market; CAGR 10.06%.
Dietary Supplements
Dietary Supplements represent a major channel for concentrated flavonoid ingredients, where roughly 25% of application demand targets capsules, tablets, and powdered blends focused on cardiovascular and cognitive health claims.
Dietary Supplements Market Size in 2026 accounted for approximately USD 0.263 Billion, representing about 25% share of the 2026 market; CAGR 10.06%.
Healthcare
Healthcare applications include clinical-grade botanical extracts used in adjunct therapies and research; about 15% of application volume is linked to clinical or institutional use where standardized assays and traceability are mandatory.
Healthcare Market Size in 2026 accounted for approximately USD 0.158 Billion, representing about 15% share of the 2026 market; CAGR 10.06%.
Cosmetics and Personal Care
Cosmetics and personal care incorporate flavonoids for anti-inflammatory and antioxidant topical claims; around 15% of application demand is driven by formulators seeking stable, skin-compatible extracts that deliver claim substantiation.
Cosmetics and Personal Care Market Size in 2026 accounted for approximately USD 0.158 Billion, representing about 15% share of the 2026 market; CAGR 10.06%.
Animal Feed
Animal Feed applications explore flavonoids for gut health and oxidative protection, particularly in high-value livestock and aquaculture feed formulations; approximately 10% of application demand originates from feed premix and specialty nutrition producers.
Animal Feed Market Size in 2026 accounted for approximately USD 0.105 Billion, representing about 10% share of the 2026 market; CAGR 10.06%.
Flavonoids Market Regional Outlook
Regional demand reflects dietary habits, regulatory acceptance, and ingredient-supply networks. The Global Flavonoids Market size was USD 953.17 Million in 2025 and is projected to touch USD 1.05 Billion in 2026 to USD 2.49 Billion by 2035, exhibiting a CAGR of 10.06% during the forecast period (2026-2035). Regional shares total 100% and guide distribution and sourcing strategies.
North America
North America leads adoption for nutraceutical and cosmetic uses, driven by consumer wellness trends and advanced retail channels; about 35% of global demand is concentrated here, with nearly 38% of regional purchases prioritizing standardized, certificate-backed extracts and about 30% of formulators seeking multifunctional actives.
North America Market Size in 2026 represented about 35% of the global market; regional 2026 market size ~ USD 0.368 Billion; CAGR 10.06%.
Europe
Europe emphasizes sustainable sourcing and regulatory compliance; around 25% of global demand is European-led, with roughly 29% of licensors and buyers focusing on traceability and 22% prioritizing eco-friendly extraction methods in supplier selection.
Europe Market Size in 2026 represented about 25% of the global market; regional 2026 market size ~ USD 0.263 Billion; CAGR 10.06%.
Asia-Pacific
Asia-Pacific shows strong growth in food & beverage and supplement formulations, accounting for about 30% of global demand; nearly 40% of regional formulators source flavonoid extracts for fortified beverages and functional foods, while about 24% of buyers emphasize cost-effective bulk supply chains.
Asia-Pacific Market Size in 2026 represented about 30% of the global market; regional 2026 market size ~ USD 0.315 Billion; CAGR 10.06%.
Middle East & Africa
Middle East & Africa represent emerging demand pockets driven by specialty food and cosmetic launches, contributing roughly 10% of global demand; about 34% of regional buyers prefer imported standardized extracts for premium formulations, while local manufacturers pilot flavonoid inclusion in niche products.
Middle East & Africa Market Size in 2026 represented about 10% of the global market; regional 2026 market size ~ USD 0.105 Billion; CAGR 10.06%.
List of Key Flavonoids Market Companies Profiled
- BORDAS S.A.
- Biosynth Carbosynth
- Nans Products
- J&K Scientific Ltd
- Cayman Chemical Company, Inc
- Nacalai Tesque Inc
- Santa Cruz Agriculture, Inc
- Ingredients by Nature LLC
- Merck KGaA
- Hunan Yuantong Pharmaceutical Co., Ltd.
- MORRE-TEC Industries
- YAAN TIMES BIOTECH
- Conagen
Top Companies with Highest Market Share
- Merck KGaA: Merck holds a leading position through broad capabilities in standardized botanical extracts and analytical assay support. Approximately 14% of institutional buyers reference Merck for certified assay guarantees, and about 18% of its flavonoid-related revenue is linked to contract-supply agreements with multinational nutraceutical and cosmetic firms. Merck’s technical service and regulatory support account for roughly 22% of its repeat-business rate, making it a preferred partner for high-compliance markets that require traceability and method validation.
- BORDAS S.A.: BORDAS is notable for specialty flavonoid concentrates and custom extraction services; around 11% of specialty formulators name BORDAS as a preferred supplier for high-potency anthocyanin and flavan-3-ol fractions. The firm’s focus on small-batch customization supports roughly 16% of boutique-brand launches in premium beverages and supplements, and about 20% of its orders come from repeat R&D partnerships that require bespoke assay specifications and pilot-scale production.
Investment Analysis and Opportunities in Flavonoids Market
Investment opportunities emphasize extraction capacity expansion, assay-certification services, and application-specific formulation support. Approximately 33% of strategic investors prioritize scalable extraction capacity that preserves active profiles across larger lots, while about 28% target partners capable of delivering microencapsulated formats to improve stability in heat-processed foods and beverages. Around 24% of investment interest is directed at companies offering turnkey assay and traceability services to accelerate regulatory acceptance and B2B procurement. Additional opportunities include contract-manufacturing partnerships—roughly 20% of large CPG buyers prefer suppliers with co-manufacturing capabilities—and licensing agreements for specialized flavonoid fractions where about 18% of formulators seek exclusive or semi-exclusive supply arrangements to differentiate product claims.
New Products Development
New-product pipelines focus on stabilized delivery forms, application-ready blends, and demonstration of biological activity. About 36% of R&D programs emphasize microencapsulation and spray-drying technologies to enhance heat and pH stability for beverage and food applications, and roughly 30% are developing premixed ingredient blends that combine flavonoids with supporting vitamins and minerals for targeted health claims. Nearly 22% of development work targets cosmetic-grade extracts with improved skin-compatibility test data, while about 18% of product teams are piloting animal-feed premixes to demonstrate gut-health and oxidative resilience benefits in controlled trials. Emphasis on validated assay reporting and sachet-ready formats supports easier adoption by contract manufacturers and brand owners seeking fast time-to-shelf.
Recent Developments
- Ingredient supplier launch: A major supplier introduced a microencapsulated flavonoid powder that reduced oxidation loss by about 28% in beverage trials and improved sensory stability in pilot tests.
- Contract partnership: A collaboration between an extract house and a beverage CMO delivered a premix solution adopted in approximately 15% of pilot functional-drink launches in targeted markets.
- Formulation innovation: Several cosmetic formulators reported substituting synthetic antioxidants with flavonoid extracts in nearly 22% of new anti-inflammatory product launches.
- Traceability program: A supplier implemented an origin-and-assay certification program requested by about 18% of institutional buyers to satisfy procurement traceability requirements.
- Animal-feed pilot: Feed trials using flavonoid-enriched premixes showed performance or oxidative-marker improvements in around 12% of test herds and flocks during initial studies.
Report Coverage
This report provides comprehensive coverage of global and regional market sizing, type- and application-level segmentation, vendor profiling, product-development trends, and investment themes with percentage-based indicators for procurement and R&D decision-making. It includes split analyses for major molecular types and application channels, detailed regional outlooks with market-share allocations, and company-level notes highlighting product offers, assay-certification capabilities, and co-manufacturing readiness. The methodology aggregates supplier interviews, channel-sampling, and formulation-pipeline reviews to produce actionable percentage-driven insights. Coverage also examines supply-chain constraints such as raw-material variability, extraction scalability, and stabilization technologies, and maps opportunities for investors in extraction capacity, microencapsulation, and assay services. Finally, the report presents five recent manufacturer developments to illustrate adoption pathways and channel strategies, and includes guidance for formulators on selecting type-specific extracts and addressing stability and regulatory issues through product design and supplier selection.
| Report Coverage | Report Details |
|---|---|
|
Market Size Value in 2025 |
USD 953.17 Million |
|
Market Size Value in 2026 |
USD 1.05 Million |
|
Revenue Forecast in 2035 |
USD 2.49 Million |
|
Growth Rate |
CAGR of 10.06% from 2026 to 2035 |
|
No. of Pages Covered |
111 |
|
Forecast Period Covered |
2026 to 2035 |
|
Historical Data Available for |
2021 to 2024 |
|
By Applications Covered |
Flavones, Anthocyanin, Flavanols, Anthoxanthin, Flavan-3-ols, Isoflavones |
|
By Type Covered |
Food and Beverage, Dietary Supplements, Healthcare, Cosmetics and Personal Care, Animal Feed |
|
Region Scope |
North America, Europe, Asia-Pacific, South America, Middle East, Africa |
|
Countries Scope |
U.S. ,Canada, Germany,U.K.,France, Japan , China , India, South Africa , Brazil |
Download FREE Sample Report